ProQR Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.

About PRQR

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.

CEO

Daniel Anton de Boer

CEODaniel Anton de Boer

Employees

166

Employees166

Headquarters

Leiden, Zuid-Holland

HeadquartersLeiden, Zuid-Holland

Founded

2012

Founded2012

Employees

166

Employees166

PRQR Key Statistics

Market cap

150.45M

Market cap150.45M

Price-Earnings ratio

-4.09

Price-Earnings ratio-4.09

Dividend yield

—

Dividend yield—

Average volume

658.22K

Average volume658.22K

High today

$1.56

High today$1.56

Low today

$1.43

Low today$1.43

Open price

$1.55

Open price$1.55

Volume

264.68K

Volume264.68K

52 Week high

$4.62

52 Week high$4.62

52 Week low

$1.07

52 Week low$1.07

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

ProQR Therapeutics

Why Robinhood?

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Show more

PRQR Key Statistics

Analyst ratings

100%

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.